Viridian Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Viridian Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Viridian Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Viridian Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Viridian Therapeutics Inc (Viridian), formerly miRagen Therapeutics, discovers and develops RNA-targeted therapeutics with a focus on microRNAs. Its approach to drug discovery, focus on R&D activities, and focus on thyroid eye disease (TED) are the company’s strengths, even as high operating expenses could be a cause for concern. The company could benefit from the promising product pipeline, the market outlook of thyroid eye disease, and the new portfolio of products. However, stringent regulations, intense competition, and rapidly changing technology could affect its operations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer